US Stock MarketDetailed Quotes

ATYR aTyr Pharma

Watchlist
  • 1.870
  • +0.130+7.47%
Close Oct 4 16:00 ET
  • 1.880
  • +0.010+0.53%
Post 19:59 ET
141.74MMarket Cap-2077P/E (TTM)

aTyr Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
235K
-96.60%353K
0
353K
0
0
10.39M
10.39M
0
Operating revenue
--0
--235K
-96.60%353K
--0
--353K
--0
--0
--10.39M
--10.39M
--0
Cost of revenue
Gross profit
Operating expense
27.71%17.32M
31.94%16.87M
-2.67%55.27M
-12.96%15.96M
-3.88%12.97M
7.74%13.56M
3.30%12.79M
66.96%56.79M
112.22%18.34M
74.59%13.49M
Selling and administrative expenses
-10.11%3.34M
2.90%3.51M
-7.17%12.98M
-6.48%3.2M
-26.92%2.65M
7.80%3.72M
-2.13%3.41M
30.05%13.98M
27.60%3.43M
39.96%3.63M
-General and administrative expense
-10.11%3.34M
2.90%3.51M
-7.17%12.98M
-6.48%3.2M
-26.92%2.65M
7.80%3.72M
-2.13%3.41M
30.05%13.98M
27.60%3.43M
39.96%3.63M
Research and development costs
42.00%13.97M
42.49%13.36M
-1.20%42.29M
-14.45%12.76M
4.58%10.32M
7.72%9.84M
5.43%9.38M
84.01%42.81M
150.38%14.91M
92.04%9.87M
Operating profit
-27.71%-17.32M
-30.10%-16.64M
-18.35%-54.92M
-100.74%-15.96M
6.50%-12.62M
-7.74%-13.56M
-3.30%-12.79M
-36.42%-46.4M
7.99%-7.95M
-74.59%-13.49M
Net non-operating interest income expense
Other net income (expense)
-17.02%1.01M
37.60%1.15M
326.20%4.52M
180.56%1.2M
415.38%1.27M
646.01%1.22M
272.77%835K
345.80%1.06M
440.51%427K
318.64%247K
Other non- operating income (expenses)
-17.02%1.01M
37.60%1.15M
326.20%4.52M
180.56%1.2M
415.38%1.27M
646.01%1.22M
272.77%835K
345.80%1.06M
440.51%427K
318.64%247K
Income before tax
-32.12%-16.31M
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
Income tax
Net income
-32.12%-16.31M
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
Net income continuous Operations
-32.12%-16.31M
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
Minority interest income
0
500.00%4K
-60.00%-8K
50.00%-1K
-100.00%-2K
-300.00%-4K
0.00%-1K
44.44%-5K
0.00%-2K
50.00%-1K
Net income attributable to the parent company
-32.16%-16.31M
-29.62%-15.49M
-11.14%-50.39M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
-34.26%-45.34M
12.13%-7.52M
-72.74%-13.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-32.16%-16.31M
-29.62%-15.49M
-11.14%-50.39M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
-34.26%-45.34M
12.13%-7.52M
-72.74%-13.24M
Basic earnings per share
-4.55%-0.23
20.69%-0.23
41.25%-0.94
3.85%-0.25
56.52%-0.2
50.00%-0.22
34.09%-0.29
9.60%-1.6
16.13%-0.26
-9.52%-0.46
Diluted earnings per share
-4.55%-0.23
20.69%-0.23
41.25%-0.94
3.85%-0.25
56.52%-0.2
50.00%-0.22
34.09%-0.29
9.60%-1.6
16.13%-0.26
-9.52%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0235K-96.60%353K0353K0010.39M10.39M0
Operating revenue --0--235K-96.60%353K--0--353K--0--0--10.39M--10.39M--0
Cost of revenue
Gross profit
Operating expense 27.71%17.32M31.94%16.87M-2.67%55.27M-12.96%15.96M-3.88%12.97M7.74%13.56M3.30%12.79M66.96%56.79M112.22%18.34M74.59%13.49M
Selling and administrative expenses -10.11%3.34M2.90%3.51M-7.17%12.98M-6.48%3.2M-26.92%2.65M7.80%3.72M-2.13%3.41M30.05%13.98M27.60%3.43M39.96%3.63M
-General and administrative expense -10.11%3.34M2.90%3.51M-7.17%12.98M-6.48%3.2M-26.92%2.65M7.80%3.72M-2.13%3.41M30.05%13.98M27.60%3.43M39.96%3.63M
Research and development costs 42.00%13.97M42.49%13.36M-1.20%42.29M-14.45%12.76M4.58%10.32M7.72%9.84M5.43%9.38M84.01%42.81M150.38%14.91M92.04%9.87M
Operating profit -27.71%-17.32M-30.10%-16.64M-18.35%-54.92M-100.74%-15.96M6.50%-12.62M-7.74%-13.56M-3.30%-12.79M-36.42%-46.4M7.99%-7.95M-74.59%-13.49M
Net non-operating interest income expense
Other net income (expense) -17.02%1.01M37.60%1.15M326.20%4.52M180.56%1.2M415.38%1.27M646.01%1.22M272.77%835K345.80%1.06M440.51%427K318.64%247K
Other non- operating income (expenses) -17.02%1.01M37.60%1.15M326.20%4.52M180.56%1.2M415.38%1.27M646.01%1.22M272.77%835K345.80%1.06M440.51%427K318.64%247K
Income before tax -32.12%-16.31M-29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M
Income tax
Net income -32.12%-16.31M-29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M
Net income continuous Operations -32.12%-16.31M-29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M
Minority interest income 0500.00%4K-60.00%-8K50.00%-1K-100.00%-2K-300.00%-4K0.00%-1K44.44%-5K0.00%-2K50.00%-1K
Net income attributable to the parent company -32.16%-16.31M-29.62%-15.49M-11.14%-50.39M-96.25%-14.76M14.38%-11.34M0.66%-12.34M1.66%-11.95M-34.26%-45.34M12.13%-7.52M-72.74%-13.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -32.16%-16.31M-29.62%-15.49M-11.14%-50.39M-96.25%-14.76M14.38%-11.34M0.66%-12.34M1.66%-11.95M-34.26%-45.34M12.13%-7.52M-72.74%-13.24M
Basic earnings per share -4.55%-0.2320.69%-0.2341.25%-0.943.85%-0.2556.52%-0.250.00%-0.2234.09%-0.299.60%-1.616.13%-0.26-9.52%-0.46
Diluted earnings per share -4.55%-0.2320.69%-0.2341.25%-0.943.85%-0.2556.52%-0.250.00%-0.2234.09%-0.299.60%-1.616.13%-0.26-9.52%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data